Agenda paper
Agenda item: 3.5
Meeting number: 2023-09
Issue arising from asynchronous prescribing
Executive summary
InstantScripts has published information on their website that patients can access asynchronous
- FOI47659
prescribing after having one telehealth consultation with one of their doctors. This paper proposes that
the Board write to InstantScripts to confirm that the proposed approach is not consistent with the
Board’s Telehealth Guidelines and may be putting practitioners at risk of regulatory action.
Action
Approve messaging and correspondence
Recommendations
That members:
1. note that the
Guidelines: Telehealth consultations with patients became effective on 1 September
Information
2023
of
2. note that the screenshot at Attachment A was published on the InstantScripts website as at 6
September 2023. It appears to be providing advice that patients can access asynchronous
prescriptions with InstantScripts after a single telehealth consultation with one of their medical
practitioners
3. confirm that the advice from InstantScripts is not consistent with the Board’s Guidelines
4. provide feedback and approve the correspondence at Attachment B, noting that the Board
regulates individual practitioners rather than InstantScripts
5. consider whether to ask Ahpra to look at whether the advertising of InstantScripts is consistent
with the provisions of the National Law and Board guidelines.
- Freedom
Attachments
Attachment A: Screenshot of communication from InstantScripts
Attachment B: Proposed letter to InstantScripts
Ahpra
Paper written by
Strategy and Policy, Medical
Paper sponsored by
Executive Officer, Medical
Medical Board of Australia
Agenda item 3.5
| 27 September 2023
| IN CONFIDENCE
Document Outline
